This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: University of Pittsburgh. Active years: 2010-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2022
Title: Mark D Alter: Innovator in Cancer Therapeutics
Introduction
Mark D Alter is a prominent inventor based in Brooklyn, NY (US). He has made significant contributions to the field of cancer therapeutics, holding a total of 3 patents. His work focuses on developing innovative solutions for cancer treatment, particularly through the use of cloned receptors.
Latest Patents
Among his latest patents is the invention titled "Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen." This invention provides an isolated nucleic acid encoding a receptor, other than an immunoglobulin, that binds to a MUC1 tumor antigen independently of a major histocompatibility complex (MHC). The invention also outlines a method for activating a signaling pathway and/or killing a cancer cell using a receptor that is similar to or is a T cell receptor.
Career Highlights
Mark D Alter is affiliated with the University of Pittsburgh, where he continues to advance his research in cancer therapeutics. His innovative work has garnered attention in the scientific community, contributing to the understanding and treatment of cancer.
Collaborations
Some of his notable coworkers include Olivera J Finn and Nehad M Alajez, who have collaborated with him on various research projects.
Conclusion
Mark D Alter's contributions to cancer therapeutics through his patented inventions highlight his role as a key innovator in the field. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile